- CIIX
concentrating on multi-pronged growth strategy
- The
company operates a top financial-information website, developing CBD
initiatives
- CIIX
offers investors unique, contemporary ROI opportunities
A fintech enterprise, ChineseInvestors.com Inc. (OTCQB: CIIX) is focusing on
its original mission of providing financial information and services to the
larger Chinese community in the United States and globally. CIIX has become a
leading financial-information website (in Chinese language character sets) for
Chinese-speaking investors in the United States and China and continues to
pursue new areas for growth in other industries as well (http://ibn.fm/TBCJS).
Via its website, www.ChineseInvestors.com,
CIIX offers an array of investor-education products and services. Additionally,
the company has recognized exceptional opportunities in the global cannabis
industry. Established in 1999, ChineseInvestors.com has its corporate
headquarters in San Gabriel, California, with offices in Flushing, New York,
and Shanghai, China (http://ibn.fm/RzkQ8).
At the heart of CIIX’s financial information and services is
its ChineseInvestors Method. This method is an inventive combination of a
disciplined investing process, web-based tools, personalized instructions and
invaluable support. The company’s investor-education products and services
include real-time market commentary and analysis as well as educational-related
services. CIIX also offers consultative services to smaller private companies
considering becoming a public company and advertising- and
public-relations-related support services.
Moreover, CIIX is laying the foundation to leverage the
increasing demand for cannabidiol (CBD)-based nutrition and health products
through its wholly owned foreign enterprise, CBD Biotech. Part of a burgeoning
contemporary trend, the company is working to be a recognized leader in the
hemp-based, CBD-oil industry. According to a Jan. 8 Research and Markets
article, a minimum of 190 companies in China include industrial cannabis in
their business scope (http://ibn.fm/MXfom).
The article also noted that CBD will become the emphasis for
the development of the cannabis industry in China in the future. Nonetheless,
industrial cannabis is not yet legal for medical applications in China.
Consequently, the market is underdeveloped, resulting in low use of industrial
cannabis.
The article further explains that as more thorough research
is conducted in the field of cannabis, the marketplace for CBD extracts is
growing. As that occurs, the application of CBD in food, cosmetics and health
products will continue to multiply.
The dynamic CBD industry is a rising market expected to
reach $2.1 billion in consumer sales this year. Furthermore, BDS Analytics and
Arcview Market Research projects that the collective market for CBD sales in
the U.S. will exceed $20 billion by 2024 (http://ibn.fm/p9O4m). BDS Analytics predicts that most CBD
product sales will take place in general retail stores instead of cannabis
dispensaries.
Astute investors may do well to note how CIIX is
well-positioned for growth in this market sector. The company has established a
three-year development plan to leverage the merging of CBD and the nutrition
with health products market in mainland China. In this marketplace, the
benefits of CBD oil have not been broadly recognized.
Based on this wholesale agreement/development plan with a
reputable CBD health brand, CIIX initiated the first-ever online, CBD-health
products store published in the Chinese language, www.ChineseCBDoil.com.
The company sells CBD-infused products both in-store and online. The company’s
website caters to an increasing number of Chinese people who are coming to
understand the manifold potential health benefits of CBD oil for the treatment
of an assortment of conditions, including anxiety, stress, poor sleep,
Alzheimer’s disease and other conditions.
ChineseInvestors.com continues to emphasize its two quality
revenue channels for sales and profit growth: fintech products and services and
CBD programs. Investors may note that in June 2019, the company anticipated the
doubling of sales over next 12 months (http://ibn.fm/wyBYE). Also, CIIX is planning an IPO of CBD
Biotech early this year. The path ahead looks promising for CIIX along with its
visionary management team, customers and investors.
For more information, visit the company’s website at www.ChineseInvestors.com
NOTE TO INVESTORS: The latest news and updates
relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
